0.9500USD-1.03%Mkt Cap: 42.00M $P/E: —1d ago
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiov…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap42.00M $
Enterprise Value17.73M $
Revenue (TTM)12.46M $
Gross Profit6.60M $
Net Income (TTM)53.38M $
Revenue/Share0.2930 USD
Last Price0.9500 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees25
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.86
PEG—
EV/EBITDA-0.92
EV/Revenue1.42
P/S3.37
P/B1.86
EPS (TTM)-0.65
EPS (Forward)-1.10
52W Range
0.500022% of range2.500
52W High2.500 USD
52W Low0.5000 USD
Profitability
Gross Margin53.66%
Oper. Margin-184.39%
EBITDA Margin-154.71%
Profit Margin434.23%
ROE192.90%
ROA85.61%
Growth
Revenue Growth5.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.81M $
CapEx (TTM)1.88M $
FCF Margin-216.78%
FCF Yield-64.29%
Net Debt-24.27M $
Net Debt/EBITDA1.26
Balance Sheet
Debt/Equity0.14
Current Ratio2.05
Quick Ratio1.29
Book Value/Sh0.5100 USD
Cash/Share0.6440 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Upside (mean)+426.3%
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.44.21M
Float26.05M
Insiders3.51%
Institutions45.68%
Short Interest
Short Ratio0.5d
Short % Float0.14%
Short % Out.0.12%
Shares Short52.92K
Short (prev mo.)42.63K
Technical
SMA 501.019 (-6.7%)
SMA 2000.9382 (+1.3%)
Beta0.85
S&P 52W Chg20.25%
Avg Vol (30d)92.91K
Avg Vol (10d)40.76K
Technical Indicators
RSI (14)46.3
MACD-0.0232
MACD Signal-0.0247
MACD Hist.+0.0015
BB Upper1.040 USD
BB Middle0.9676 USD
BB Lower0.8954 USD
BB Width14.91%
ATR (14)0.0679 USD
Vol Ratio (20d)8.43x